Skip to main content

Vaxart, Inc.

VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000072444

No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Vaxart, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of VXRT: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders9687−9
Shares18.5M16.3M−2.16M (−11.7%)
Value$13.9M$9.38M−$4.56M (−32.7%)

New holders (7)

Institutions that held Vaxart, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to VXRT in Q4 2023
InstitutionSharesValue% of portfolio
Connective Capital Management, LLC387,372$221.9K0.19%
Virtu Financial LLC43,043$25.0K0.00%
Edmond de Rothschild Holding S.A.41,000$23.5K0.00%
Financial Engines Advisors L.L.C.10,000$5.73K0.00%
HRT Financial LP10,009$5.00K0.00%
Point72 Asia (Singapore) Pte. Ltd.6,900$3.95K0.00%
LM Advisors LLC6,225$3.56K0.00%

Sold out (16)

Institutions that held Vaxart, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.